Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label [0.03%]
儿童脂肪肝疾病标准的比较评估：MASLD、ESPGHAN、NASPGHAN 和 NAFLD - 确定最优儿科标签
Chih-Wen Wang,Po-Chin Huang,Chia-Yen Dai et al.
Chih-Wen Wang et al.
Almost identical values of various non-invasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia [0.03%]
亚洲NAFLD和MASLD的各种非创性肝纤维化和脂肪变指数值接近相同
Masahito Nakano,Machiko Kawaguchi,Takumi Kawaguchi
Masahito Nakano
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient [0.03%]
非创伤性试验对门脉高压的预测性能与肝静脉压力梯度相当
Mathias Jachs,Lukas Hartl,Benedikt Simbrunner et al.
Mathias Jachs et al.
Background & aims: Non-invasive tests to assess the probability of clinically significant portal hypertension (CSPH) - including the ANTICIPATE±NASH models based on liver stiffness measurement and platelet count±BMI, an...
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver [0.03%]
单细胞、单核和空间转录组学对健康和PSC人肝脏免疫景观的特征分析
Tallulah S Andrews,Diana Nakib,Catia T Perciani et al.
Tallulah S Andrews et al.
Background & aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease for which there is an unmet need to understand the cellular composition of the affected liver and how it underlies di...
Reply to: "Stop using the misidentified cell line LO2 as a human hepatocyte" [0.03%]
《停止使用误识的LO2细胞系作为人源性肝细胞》
Qian Song,Xiang Zhang,Jun Yu
Qian Song
Corrigendum to "Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine" [J Hepatol (2023) 937-946] [0.03%]
对“建模在埃及和乌克兰怀孕期间丙型肝炎筛查和治疗策略的潜在有效性”[J 肝病学 (2023) 937-946] 的勘误
Nadia Hachicha-Maalej,Intira Jeannie Collins,Anthony E Ades et al.
Nadia Hachicha-Maalej et al.
Published Erratum
Journal of hepatology. 2024 Feb;80(2):379. DOI:10.1016/j.jhep.2023.12.013 2024
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19] [0.03%]
《J Hepatol》文章勘误："SIRT5 rs12216101 T>G变异与非酒精性脂肪肝病患者的肝脏损伤和线粒体功能障碍有关" [J Hepatol 80 (2024) 10-19]
Federico Salomone,Rosaria Maria Pipitone,Miriam Longo et al.
Federico Salomone et al.
Published Erratum
Journal of hepatology. 2024 Feb;80(2):378. DOI:10.1016/j.jhep.2023.12.002 2024
Fernando Díaz-Fontenla,Aránzazu Caballero-Marcos,Isabel Peligros et al.
Fernando Díaz-Fontenla et al.
Reply to: "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany" [0.03%]
《回复：“基于人群的筛查有效：将乙型和丙型肝炎筛查纳入德国普通健康检查中的效果”》
L Alexa Thompson,Carmen L Charlton
L Alexa Thompson
Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score [0.03%]
CLivD评分预测中国成年人慢性肝病风险的外部验证研究
Yuanjie Pang,Fredrik Åberg,Zhengming Chen et al.
Yuanjie Pang et al.